klaw.png
Kuehn Law Encourages NS, NXPL, IP, and RXMD Investors to Contact Law Firm
17 avr. 2024 10h18 HE | KUEHN LAW, PLLC
Kuehn Law investigates potential claims related to proposed mergers of NS, NXPL, IP, and RXMD. Shareholders urged to contact for details.
Whitelogolarge.jpg
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger – NS, CTLT, SCX, EVBG
04 avr. 2024 10h53 HE | Monteverde & Associates PC
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the...
Whitelogolarge.jpg
ALERT: Juan Monteverde Encourages the Shareholders of TARO, BATL, NS, INBX to Take Action
24 janv. 2024 17h21 HE | Monteverde & Associates PC
NEW YORK, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
QUOIN-COLORED-LOGO (1).png
Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
13 déc. 2023 08h30 HE | Quoin Pharmaceuticals, Inc.
Positive initial data and clean safety profile catalyze optimization planSize of both ongoing clinical trials significantly increasedLower dose eliminated from blinded trialDosing frequency changed to...